The need to non-invasively see and track cells in living persons is indisputable. Emerging treatments using stem cells and immune cells are poised to most benefit from cell tracking, which would visualize their behavior in the body after delivery. Clinicians require such data to speed these cell treatments to patients. Researchers at University of California, San Diego School of Medicine describe a new highly sensitive chemical probe that tags cells for detection by MRI.
Each year, at precisely the same moment, thousands of graduating medical school students across the country simultaneously tear open an envelope. Inside, there is a single sheet of paper and on it, a handful of words. Those words will inform each graduate where he or she will do their residencies, where each will spend the first several years of their careers as working doctors.
Researchers at University of California, San Diego School of Medicine and Shiley Eye Institute, with colleagues in China, have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses.
The CENIC networking consortium will give its Innovations in Networking Award for Research Applications to UC San Diego archaeologist Thomas Levy for his work to digitize archaeological excavations using a suite of cyberarchaeology tools.
A team of biologists and physicists at UC San Diego has uncovered in detail the dynamic process that allows the multi-tentacle Hydra, a tiny freshwater animal distantly related to the sea anemone, to open and close its mouth.
UC San Diego Health and Vantage Oncology are collaborating to provide comprehensive cancer care services to patients in Imperial Valley. Through a joint venture, UC San Diego Health and Vantage will operate Imperial Valley Radiation Oncology. Patients will have access to advanced radiation technologies as well as clinical trial interventions and specialty care consultations with UC San Diego Health and Moores Cancer Center.
